Skip to content

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Stryker logo
StrykerSYK
$415M+227%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$10.8M+27.9%
Enovis logo
EnovisENOV
-$28.85M+35.7%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Calculated from Orthofix Medical Inc.’s reported figures.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s free cash flow?
Orthofix Medical Inc. (OFIX) reported free cash flow of -$28.27M in Q1 2026.
How has Orthofix Medical Inc.'s free cash flow changed year-over-year?
Orthofix Medical Inc.'s free cash flow decreased by 12.5% year-over-year, from -$25.13M to -$28.27M.
What is the long-term trend for Orthofix Medical Inc.'s free cash flow?
Over 2 years (2021 to 2023), Orthofix Medical Inc.'s free cash flow has grown at a 1139.5% compound annual growth rate (CAGR), from $690K to -$106.01M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.